Asensus Surgical, Inc. (ASXC) Reports In-Line Q4 EPS

Asensus Surgical, Inc. (NYSE: ASXC) reported Q4 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $2.48 million versus the consensus estimate of $1.51 million.

For earnings history and earnings-related data on Asensus Surgical, Inc. (ASXC) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Delta Air shares slip despite strong outlook, Melius says
• FDA approves Padcev plus Keytruda for muscle-invasive bladder cancer